In another acquisition related to oncology treatments, Sanofi-Aventis (SNY) will buy...

|About: Sanofi (SNY)|By:, SA News Editor

In another acquisition related to oncology treatments, Sanofi-Aventis (SNY) will buy closely-held TargeGen to add treatments for certain forms of leukemia and blood disorders. Sanofi will pay $75M at the deal's close, and as much as $560M total, depending on the stages reached in drug development. (PR)